Background--Although frailty has been associated with increased risks for hospitalization and mortality in chronic heart failure, the precise average effect remains uncertain. We performed a systematic review and meta-analysis to summarize the hazards for mortality and incident hospitalization in patients with heart failure and frailty compared with those without frailty and explored the heterogeneity underlying the effect size estimates.
after heart transplantation 8 or heart function replacement. 9 Characterizing frailty status in patients with HF may provide clinicians an indicator for gauging disease severity, prognosis, and disease progression or reversal. Although most studies have shown increased risks for hospitalization and mortality in chronic HF, 2-7 offset by 2 relatively small studies with borderline neutral results, 10 ,11 the precise average effect of frailty has not previously been summarized with certainty. Recently, a systematic review included a total of 8 articles from 2004 to 2014 and suggested that patients with HF and frailty had increased risks for adverse outcomes. 12 However, 2 of 8 articles 5, [13] [14] [15] in that study contained data from overlapping studies (ie, double counting), and no meta-analysis was performed. Since 2014, 6 additional independent studies [2] [3] [4] 11, 16, 17 with potential to be included in a meta-analysis have been published. Recently, a systematic review and meta-analysis has summarized data on the prevalence of HF-associated frailty from 26 studies at 44.5% after removal of 14 overlapping studies. 18 However, that study did not assess the impact or effect size of frailty on adverse outcomes, including death and hospitalization, and included patients with acute HF and those receiving cardiac resynchronization therapy, left ventricular assist device (LVAD), or heart transplant. 18 In this study, we have carefully summarized the existing evidence, explored for heterogeneity, and completed the first meta-analysis of frailty on the hazards of mortality and incident hospitalization in patients with chronic HF.
Methods Data Sources and Search Strategy
The data that support the findings of this study are available from the corresponding author on reasonable request. From October 2016 to April 2018, we searched MEDLINE, EMBASE, and the Cochrane databases for articles published between January 1966 and March 2018. Study design ( Figure 1 and Figure S1 ) and data reporting were compliant with MOOSE, as recommended in the EQUATOR Network guidelines. 19, 20 Institutional Review Board approval was not required for this systematic review and meta-analysis.
Eligibility Criteria
The following Medical Subject Headings or MeSH search terms were used: "frailty AND heart failure," "frail AND heart failure," "fragility AND heart failure," "gait speed AND heart failure," "grip strength AND heart failure," "weight loss AND heart failure," and "cognitive frailty AND heart failure." Fragility is a term used by some European investigators with whom we have individually confirmed about its use in their publications as being synonymous with frailty for the purpose of this study. Literature search was independently performed by 2 reviewers (E.F. and X.Y.), according to a prespecified workflow. Conflicting findings were resolved by a third researcher (J.W.). The inclusion criteria were as follows:
(1) frailty assessed using validated assessment instruments; (2) confirmed diagnosis of HF on the basis of international criteria and guideline definitions 21, 22 ; (3) human individuals;
and (4) articles in English. The exclusion criteria were as follows: (1) unpublished data, abstracts, conference proceedings, comments, letters, correspondences, editorials, or duplicates; (2) studies without any relevance to the clinical outcomes of hospitalization and mortality; (3) studies that investigated the effects of medical or surgical intervention, including cardiac resynchronization therapy, LVAD, and cardiac transplantation; (4) data on acute HF; and (5) non-English articles.
Data Extraction
The main clinical outcomes in this meta-analysis were allcause mortality and hospitalization. Where data on all-cause hospitalization were not available, 3 cardiac hospitalization
Clinical Perspective
What Is New?
• This meta-analysis is the first to summarize the literature and report on a 1.5-fold increase in the adverse outcome of death or incident hospitalization associated with frailty in patients with chronic heart failure during a follow-up of <2 years.
• The Fried phenotype, an often-used frailty assessment scale originally developed from the Cardiovascular Health Study, estimated a higher mortality rate of 16.9% compared with that of the combined (Fried and non-Fried) assessment, whereas the estimate for incident hospitalization was indistinct between Fried and the combined assessments.
What Are the Clinical Implications?
• Since publication of "Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society" (2016), and the Geriatric Cardiology Council document of the American College of Cardiology (2018), there have been increasing efforts to tackle heart failure and geriatric cardiovascular disease using multidomain approaches.
• The Fried phenotype is simple to use, provides prognostic information, and assesses for domain-based physiological insufficiencies that may lend itself to daily clinical practice and screening for latent chronic heart failure.
• Frailty associated with heart failure may be reversible and a target for intervention.
was used. A structured data form was used to organize information [2] [3] [4] [5] [6] [7] 10, 11, [13] [14] [15] [16] [17] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] (Table) . Two reviewers (E.F. and X.Y.) extracted the raw data and independently evaluated study quality (described later).
Data Synthesis and Statistical Analysis
The effect sizes of risks were reanalyzed and recalculated as hazards, pooled, and represented by adjusted or unadjusted hazard ratios (HRs) for the clinical outcomes of all-cause mortality or hospitalization in frail and nonfrail patients with chronic HF. When available, all-cause rather than cardiac hospitalization was used. This is justified by evidence in the literature that hospitalizations secondary to HF with preserved left ventricular ejection fraction (EF) are often attributable to complex comorbidities. 21, 22 Of 6 studies included in the metaanalysis of frailty on incident hospitalization, 5 used all-cause hospitalization and 1 used cardiac hospitalization 3 as end points. Where possible, adjusted, rather than unadjusted, HRs were used (Table S1 ).
To standardize classification of frailty/nonfrailty status, we reclassified prefrailty, a nonexistent category in some frailty assessment scales, 38, 39 as nonfrailty. To minimize data redundancy and double counting, 40 we contacted authors of the original studies for clarification and data reanalysis, where necessary. Among a total of 10 groups authoring 20 studies, 8 groups responded to our query with clarification and/or assisted in reanalysis (response rate, 80%). Where data redundancy from overlapping studies was suspected or in cases in which the original authors could not be reached, we proceeded to remove those articles from further analysis. The research group of Bay es-Gen ıs, Lup on, and Gastelurrutia consolidated their cohort data from 3 publications and reanalyzed risk estimates. 3, 15, 34 Originally presented as odds ratios in the study of Vid an and colleagues, 4 the risk for rehospitalization was recalculated as HRs using data from telephone interviews at 1, 3, 6, and 12 months after hospital discharge. For 66 patients in that study who did not have the exact dates of rehospitalization, the time to hospitalization was imputed using the calculated mean time to hospitalization from the remaining 340 patients. The data on mortality and hospitalization from the original article by Ferguson and colleagues were newly calculated and presented as HRs. Results from eligible studies were pooled and metaanalyzed using a random-effects model with inverse-variance weighting. Heterogeneity of studies was assessed using Cochrane's Q statistic and I 2 . Prespecified I 2 threshold values of 25%, 50%, and 75% were used to indicate low, moderate, and high levels of heterogeneity, respectively. A 2-tailed P<0.05 was considered statistically significant. Analyses were performed using Review Manager 5.3 (The Cochrane Collaboration) and R 3.3.3 (R Foundation).
Assessment of Publication Bias and Study Quality
Publication bias was assessed using funnel plots and DuvalTweedie's trim-and-fill test ( Figure S2 ).
Results

Search and Study Selection
Our query to EMBASE, MEDLINE, and Cochrane databases returned 6886 records ( Figure 1 and Figure S1 ). After further screening and evaluation, 6641 irrelevant records and 217 ineligible full-text articles were excluded. Among 28 eligible articles, 2-7,10,11,13-17,23-37 8 and 6 unique studies were finally included in the meta-analysis for allcause mortality and incident hospitalization, respectively ( Figure 1 and Table) .
Characteristics of Patients With Chronic HF
Among studies that reported on the prevalence rates of atrial fibrillation, ischemic heart disease (coronary artery disease), hypertension, and/or diabetes mellitus, the respective median prevalence rates were 53% (quartile (Figure 2A and Table S2 ). The median duration of follow-up for 2645 patients in the 8 studies 2-6,10,11,16 was 1.82 years (quartile 1-quartile 3, 1.0-3.9 years). In studies that used only the Fried phenotype for frailty assessment (n=5 studies; Figure 2B ), the effect size estimate was increased by 16.9% (HR, 1.80; 95% CI, 1.41-2.28; P<0.001; n=1127 patients). 2, 4, 5, 10, 11 Irrespective of the frailty assessment instrument used, the level of study heterogeneity was low (I 2 =0%) (Figure 2A and 2B).
Frailty Is Significantly Associated With an Increased Rate of Hospitalization in Chronic HF
During a median follow-up of 1.12 years (quartile 1-quartile 3, 1-2 years), the presence of frailty was significantly Reference number is shown after year of publication (see References for details). A, Effects of frailty on all-cause mortality in patients with chronic heart failure (HF). B, Effects of frailty on all-cause mortality in patients with chronic HF in 5 studies that used the Fried phenotype for frailty assessment. IV weighting and random-effects model were used in the meta-analysis. Reference number is shown after year of publication (see References for details). C, Effects of frailty on incident hospitalization in patients with chronic HF. Six unique studies with nonoverlapping data are shown. IV weighting and random-effects model were used in the meta-analysis. Reference number is shown after year of publication (see References for details). D, Effects of frailty on incident hospitalization in patients with chronic HF in 4 studies that used the Fried phenotype for frailty assessment. IV weighting and random-effects model were used in the meta-analysis. Reference number is shown after year of publication (see References for details). CI indicates confidence interval; df, degrees of freedom; HR, hazard ratio. Figure 2C and Table S1 ). In 4 studies that used Fried assessment, 2,4,7,11 the estimate was, however, similar (adjusted HR, 1.57; 95% CI, 1.30-1.89; P<0.001; n=1142 patients) to the overall pooled estimate ( Figure 2D ). The level of heterogeneity between studies was also low (I 2 =0%) ( Figure 2C and 2D) .
Publication Bias and Study Quality
Although the effect size estimates for mortality fell within the pseudo 95% confidence limits of the funnel plot ( Figure S2A ), we proceeded to using the trim-and-fill test for ascertainment and found no significant difference with or without adjustment (adjusted HR, Figure S2C and Figure 2A ), thereby ruling out large publication bias effects. The high quality of the included studies 2-7,10,11,16 was indicated by a composite score of ≥7 on the Newcastle-Ottawa scale 41 (Table S3 ).
Discussion
Frailty is increasingly recognized as an important target for monitoring and intervention in contemporary cardiovascular care and management. 42, 43 Clinical pathways using frailty assessment in management decision making and for determination of procedural eligibility have previously been shown to affect patient outcomes and provide prognostic indication of well-being and survival associated with procedures, ranging from transcatheter and surgical aortic valve replacement to heart transplantation. [43] [44] [45] However, the precise negative effects of frailty on chronic HF 2-7,10,11 have not been previously established with certainty. This systematic review and meta-analysis is the first to summarize the adverse impact of hospitalization and mortality associated with frailty in chronic HF. Mortality and incident hospitalization were both significantly increased by %1.5-fold in >1300 patients with HF with frailty, compared with >1200 patients with HF without frailty (Figure 2 ). This study has reanalyzed and recalculated risk estimates as HRs, consolidated data from 3 independent sources (study cohorts from Barcelona, Spain; Madrid, Spain; and Sydney, Australia) to minimize or eliminate double counting, and focused on patients with chronic HF. Current available studies in the literature have not included any meta-analyzed data on mortality and hospitalization associated with frailty in HF, 12, 46 and frailty prevalence was the sole focus of another recently published meta-analysis that included patients with acute decompensated HF, patients with chronic HF, and patients receiving cardiac resynchronization therapy, LVAD, and heart transplant. 18 One of the major findings in this study was the higher estimate of hazard for mortality, but not incident hospitalization, by the Fried phenotype compared with the overall pooled (combined Fried and non-Fried) estimates (Figure 2) . The reason for this observation is unclear, but it can be possibly explained by the overlapping characteristics (and pathophysiological features) between functional components of the Fried phenotype (eg, progressive unintentional weight loss and weakness) and cardiac cachexia of advanced chronic HF, which carries a poor prognosis. However, the concept of cardiac cachexia cannot be simply explained by reduced body mass index alone because this relationship is complex, 43 depending on the population or patient subset with HF, the cause, the pathogenesis, and the chronicity of the pathophysiological features. 2001 is based on the concept of aging-related failure of homeostasis in physiologic systems (or domains) represented by 5 specific items: low physical activity, fatigue, shrinkage (or unintentional weight loss over a defined period), weakness, and slowness. The 5 items of the Fried phenotype are scored out a total of 5 points, with 1 point awarded for each positive item; scores of ≥3, 1 to 2, and 0 indicate subjects in frail, prefrail, and robust states, respectively. The prefrail state may be a clinically relevant indicator of underlying cardiometabolic disorder, reduced physiological reserve, and a window of opportunity for workup and intervention before development of systemic decompensation. However, the absence of prefrailty in some frailty assessment scales precluded comparison between studies for this condition. Another major frailty concept is centered on the frailty index developed by Rockwood et al. 50 The frailty index is based on a cumulative multiple deficit approach, using clinical and laboratory variables with an emphasis on the number rather than type of derangements. As noted, these and other commonly used frailty assessment tools, including the modified Fried-based FRAIL scale that obviates physical testing (eg, hand grip strength and walking tests 51 ) with improved clinical operationality, have been previously compared in specific settings and found to DOI: 10.1161/JAHA.117.008251
Journal of the American Heart Association perform similarly. 51, 52 Other surrogate markers of frailty include gait speed, 53, 54 which has been reported to offer prognostic information in patients with HF. 55 Our search strategy in this study has included individual components of frailty assessment scales (see Methods) to maximize identification of articles in the literature. A major challenge lies in the harmonization of a wide range of frailty assessment scales used in studies. Woo and coworkers have previously reported that the major frailty scales (frailty index by Rockwood and Mitnitski, Fried phenotype from the Cardiovascular Health Study, FRAIL scale, and the Hubbard modified frailty score) perform similarly in predicting death and physical limitation in a geriatric study population. 51 Chong and colleagues found that several frailty assessment instruments (frailty index, FRAIL scale, Tilburg Frailty Index, and Clinical Frailty Scale) tested did not significantly differ in their ability to diagnose frailty. 52 Those findings suggest that pooling of studies for meta-analysis can be feasible and informative for the specific purpose of this study, as supported by available evidence in the literature. HF and aging-related frailty share common signs, symptoms, and manifestations, including sarcopenia or skeletal muscle weakness, impaired cardiorespiratory and physical fitness, increased inflammatory burden, 56 and central nervous system dysfunction. 57, 58 Although definitions and assessment scales do vary, there has been impetus toward a universal definition of frailty in the geriatric professional community. 1, 59, 60 Currently, frailty is not routinely assessed for or systematically categorized in patients with HF. 1, 21, 22, 42, 61 However, findings from this and other studies encourage the use of frailty assessment for risk stratification of patients with HF to inform prognosis and management decisions. Recent data from the LVAD and heart transplant literature suggest that frailty in patients with advanced HF can be reversed by intervention or organ replacement 8, 43 and that frailty is not necessarily age or functional class related, 18 suggesting that inclusion of frailty assessment in patients with HF can inform outcomes. Indeed, Jha and colleagues have shown that pre-LVAD or pretransplant frailty status has a significant impact on survival after LVAD implantation or heart transplantation. 43 There are several limitations in this study. First, the competing risks between hospitalization and mortality across time could not be assessed given the limitations inherent in the original studies. 62 Second, hospitalization as an outcome measure is complex and may be HF associated, cardiac related, or unrelated to cardiovascular events. 63, 64 Details on hospitalization and contemporary metrics (eg, 30-day readmission and length of stay) for characterizing hospitalization were unavailable from the included studies. Future studies using standardized metrics may improve accuracy of risk estimates. Third, there were insufficient data in the available articles to perform a meta-analysis on HF subtypes (eg, HF with reduced EF and HF with preserved EF). 21, 22 Although some studies have shown that the adjusted survival and hospitalization rates are similar between HF subtypes, 47, 65 there is a need for future studies to clarify this.
In conclusion, this meta-analysis provides the first summary on the effects of frailty on mortality and hospitalization and confirms the significant negative impact of frailty on chronic HF. Stratification of patients with HF by frailty status provides prognostic information and may inform priorities for HF interventions and management. ACEI, angiotensin converting enzyme inhibitor; DM, diabetes mellitus; HF, heart failure; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal prohormone of brain (B-type) natriuretic peptide; NYHA, New York Heart Association functional class.
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*Newcastle-Ottawa Scale categorizes the quality of a study based on summed total points: low, 0 to 3 points; intermediate, 4 to 6 points; high, 7 to 9 points. † Fragility is synonymous with frailty in this study. ‡ See also References (Supplemental Material).
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